Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 457 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No Score Clear all

Conditions: Labor Onset and Length Abnormalities, Induced; Birth
Interventions: Dilapan, Misoprostol; Device · Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 307 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: New York, New York • Galveston, Texas

Conditions: Diabetes Mellitus, Cardiovascular Diseases, Hypertension
Interventions: Centralized support for population health management activities; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 108,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Leukemia, Aplastic Anemia, Bone Marrow Failure Syndromes, SCID
Interventions: PCA plus methadone (Experimental), PCA Alone (SOC); Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 6 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Tibial Plateau Fracture
Interventions: bupivacaine; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Chest Pain, Acute Myocardial Infarction
Interventions: Electronic risk alerts; Other
Lead sponsor: Harvard Vanguard Medical Associates; Other
Eligibility: 30 Years and older
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Boston, Massachusetts • Newton, Massachusetts

Conditions: Hematopoietic and Stem Cell Transplant
Interventions: General Health Module-Baseline Adolescent-Self Report (13-18 years), General Health Module-Follow Up Adolescent-Self Report (13-18 years), General Health Module-Baseline Parent Report-Adolescent (13-18 years), General Health Module-Follow Up Parent Report-Adolescent (13-18 years), General Health Module-Baseline Parent Report-School Age (5-12 years), General Health Module-Follow Up Parent Report-School Age (5-12 years), Demographic Data Form, SCT Daily Activity Log, The Functional Independence Measure for Children, Manual Muscle Testing, 3-Minute Step Test, HSCT Module-Follow Up Adolescent-Self Report (13-18 years), HSCT Module-Follow Child-Self Report (5-12 years), HSCT Module-Follow Up Parent Report-adolescent (13-18 years), HSCT Module-Follow Up Parent Report-School Age (5-12 years); Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 7 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Kidney Cancer, Renal Cancer, Renal Neoplasm
Interventions: Ketorolac, Acetaminophen, Oxycodone, Hydromorphone, Ibuprofen; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 99 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Musculoskeletal Pain, Musculoskeletal Injury
Interventions: Execise Group, Control Group; Other
Lead sponsor: Loyola University; Other
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Sepsis, Venous Thromboembolism, Disseminated Intravascular Coagulation
Interventions: Diagnosis of both VTE and sepsis; Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Whippany, New Jersey

Conditions: Cognitive Impairment, Dementia
Interventions: No interventions; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years to 90 Years
Enrollment: 1,892 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 17
States / cities: Los Angeles, California • Sacramento, California • San Francisco, California + 12 more

Conditions: Pediatric Obesity
Interventions: Group A, Group B; Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 11 Years to 21 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 3
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Neuroblastoma
Interventions: 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic; Biological
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Months and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Anesthesia, Local, Phrenic Nerve Paralysis, Upper Extremity Injury, Phrenic Nerve Palsy on the Left, Phrenic Nerve Palsy on the Right
Interventions: Normal saline injected via interscalene nerve catheter, Placebo; Procedure · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Obsessive Compulsive Disorder
Interventions: CBT treatment for OCD based on Exposure & Response Prevention (EX/RP) and when indicated medication treatment; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 5 Years to 17 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Rheumatoid Arthritis, Trauma, Thyroid Nodule, Cancer
Interventions: Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001, conventional syringe - BD Ref 309604; Device
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 437 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Obesity
Interventions: Control, Nutriscore Label, Adapted Peruvian Nutrient Label, Guideline Daily Amount Label; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 64 Years
Enrollment: 8,071 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Stress, Psychological, Anxiety
Interventions: Cognitive Stress Testing; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Communication
Interventions: Communication Skills Training, Profile feedback, Maslach burnout inventory, Emotion Regulation Skills Question (ERSQ), Semi-structured interview, Priming; Behavioral · Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Surgical Wound, Tissue Adhesion
Interventions: Subcuticular Skin Closure, Tissue Adhesives; Procedure · Device
Lead sponsor: St. John Hospital & Medical Center; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Head and Neck Squamous Cell Carcinoma
Interventions: Magrolimab, Pembrolizumab, Docetaxel, 5-FU, Cisplatin, Carboplatin, Zimberelimab; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 22
States / cities: Chandler, Arizona • Duarte, California • Los Angeles, California + 19 more

Conditions: Venous Thromboembolism, Pediatrics, Deep Vein Thrombosis, Pulmonary Embolism
Interventions: Hematology Review; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 0 Years to 21 Years
Enrollment: 17,427 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Polycystic Ovarian Syndrome
Interventions: Birth control, Birth control plus Brevail; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Spinal Cord Stimulation
Interventions: Spinal Cord Stimulation (SCS) Trial; Procedure
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury, Mild Cognitive Impairment
Interventions: No Intervention is used for this study but all subjects will be asked to complete electroencephalogram (EEG) testing and an MRI scan., No intervention is used for this study but all subjects will be asked to complete a venous blood draw procedure and a lumbar puncture procedure.; Device · Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 30 Years to 90 Years
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Comparison of Misoprostol Ripening Efficacy With Dilapan

Implementation of a Population Health Chronic Disease Management Program

Methadone as an Alternative Treatment for Children Underdoing HSCT

Continuous Femoral Nerve Block With a Tibial Plateau Fracture

Risk Score Alerts for Chest Pain Care

Deconditioning in Transplant

NSAID Use After Robotic Partial Nephrectomy

Surgeon Core-strengthening Program as a Modifier for Exertion Associated With Vaginal Surgery

An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Healthcare Text Messaging to Improve Diet, Physical Activity and Weight Loss in a Pediatric Lipid Clinic

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow

Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade

Overlapping Neural Circuits in Pediatric OCD

Reciprocating Medical Devices - a Study of a New Safety Device

Testing Product Messages for Colombia

Cognitive and Biological Responses in Stress

Emotion Regulation and Burnout Impact on Communication Documentation

Skin Closure With Tissue Adhesives vs. Subcuticular Suture After Robotic Urogynecologic Procedures

Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma

Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events

Flaxseed Lignan (Brevail)

Prospective Evaluation of the Optimal SCS Trial Length

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)